Redefining Cardiac Involvement and Targets of Treatment in Systemic Immunoglobulin AL Amyloidosis.

Autor: Porcari A; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom.; Centre for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI), University of Trieste, Trieste, Italy.; European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart (ERN GUARD-HEART), Trieste, Italy., Masi A; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom., Martinez-Naharro A; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom., Razvi Y; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom., Patel R; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom., Ioannou A; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom., Rauf MU; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom., Sinigiani G; Department of Cardio-Thoraco-Vascular Sciences and Public Health, University of Padua, Padua, Italy., Wisniowski B; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom., Filisetti S; Cardiology University Department, Heart Failure Unit, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy.; Faculty of Medicine, University of Milano, Milan, Italy., Currie-Cathey J; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom., O'Beara S; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom., Kotecha T; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom., Knight D; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom., Moon JC; Institute of Cardiovascular Science, University College London, London, United Kingdom.; Barts Heart Centre, West Smithfield, London, United Kingdom., Sinagra G; Centre for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI), University of Trieste, Trieste, Italy.; European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart (ERN GUARD-HEART), Trieste, Italy., Virsinskaite R; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom., Gilbertson J; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom., Venneri L; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom., Petrie A; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom., Lachmann H; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom., Whelan C; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom., Kellman P; National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland., Ravichandran S; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom., Cohen O; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom., Mahmood S; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom., Manisty C; St Bartholomew's Hospital, London, United Kingdom., Hawkins PN; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom., Gillmore JD; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom., Wechalekar AD; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom., Fontana M; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom.

Publikováno v: JAMA cardiology [JAMA Cardiol] 2024 Nov 01; Vol. 9 (11), pp. 982-989.